GMED

Globus Medical, Inc.

$75.23

-1.49%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives.

Source: Yahoo Finance
AI summary

Price & performance

1M+8.6%
3M+3.4%
YTD-7.3%
1Y+27.9%
52-week range—
Beta0.93
Full chart and returns against a benchmark

Q-Score

83/ 100

Quality against peers; 50 is the peer median.

Growth69
Risk71
Performance57
Valuation74
Profitability80
Leverage80
Sentiment61
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$2.9B+16.7%
Net income$537.9M+422.3%
Net margin18.3%+14.2 pts
Historical fundamentals

Revenue exposure

19%of revenue from outside the US
United States81%
Non-US19%
Regions, segments, customers and suppliers

Valuation

GMEDIndustryP/E17.9029.61P/S3.183.49EV/EBITDA9.9018.38P/B2.083.39PEG0.570.57
Dividend yield0.00%
Every valuation metric

Earnings

Nov 5next report
EPS estimate$1.20
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate